TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33721505

Group type: EXPERIMENTAL
Intervention: Traditional bolus cement technique
Number of subjects: 18

Group type: COMPARATOR
Intervention: Swirl cement technique
Number of subjects: 18
Study: 34450101

Group type: EXPERIMENTAL
Intervention: Multimodal intervention (protocol dissemination, education for healthcare professionals and patients, feedback on performance) for 12 months
Number of subjects: 4478

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 4478
Study: 32731928

Group type: EXPERIMENTAL
Intervention: Sacubitril/Valsartan
Number of subjects: 1135

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 1135
Study: 33804259

Group type: EXPERIMENTAL
Intervention: High-protein dairy milk + resistance training (MR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isoenergetic carbohydrate + resistance training (PR)
Number of subjects: 30
Study: 33032644

Group type: EXPERIMENTAL
Intervention: Pessary self-management teaching, self-management information leaflet, follow-up phone call, access to local telephone support.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clinic-based pessary care (standard at their centre).
Number of subjects: 0
Study: 37076838

Group type: EXPERIMENTAL
Intervention: depression education fotonovela
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33414139

Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 232

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 232

Group type: COMPARATOR
Intervention: Waiting-list group
Number of subjects: 232
Study: 32286620

Group type: EXPERIMENTAL
Intervention: 1 egg per day for 6 months
Number of subjects: 660

Group type: COMPARATOR
Intervention: Control group (no eggs provided)
Number of subjects: 660
Study: 35394723

Group type: EXPERIMENTAL
Intervention: Alental cream
Number of subjects: 131

Group type: COMPARATOR
Intervention: Aertal cream
Number of subjects: 131
Study: 34458708

Group type: EXPERIMENTAL
Intervention: Pooled RT-qPCR testing using oropharyngeal swabs or buccal swabs
Number of subjects: 3970

Group type: EXPERIMENTAL
Intervention: Pooled saliva swabs using the 'lolli method'
Number of subjects: 3970

Group type: COMPARATOR
Intervention: Cumulative incidence in primary schools
Number of subjects: 3970

Group type: COMPARATOR
Intervention: Cumulative incidence in secondary schools
Number of subjects: 3970
Study: 32972259

Group type: EXPERIMENTAL
Intervention: Aversive video
Number of subjects: 562

Group type: COMPARATOR
Intervention: Control video
Number of subjects: 562
Study: 35501931

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP) treatment initiated one day post-injury
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP) treatment
Number of subjects: 2
Study: 32014842

Group type: EXPERIMENTAL
Intervention: PATHway (PW) intervention group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care (UC) control group
Number of subjects: 120
Study: 34318563

Group type: EXPERIMENTAL
Intervention: RNA interference-mediated knockdown of lnc94638 expression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35272249

Group type: EXPERIMENTAL
Intervention: Dry-needling together with exercise therapy (DNG)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Exercise-only group (EG)
Number of subjects: 70
Study: 33222767

Group type: EXPERIMENTAL
Intervention: MD1003 (oral biotin 100 mg three times daily)
Number of subjects: 642

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 642

Group type: EXPERIMENTAL
Intervention: MD1003
Number of subjects: 642
Study: 34989016

Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 17
Study: 34592639

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine infusion
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine infusion
Number of subjects: 71

Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Low-dose ketamine infusion
Number of subjects: 71
Study: 35252455

Group type: EXPERIMENTAL
Intervention: Acutreatment (n=30)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sham Acutreatment (placebo, n=27)
Number of subjects: 57
Study: 33781394

Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery Program (10 modules, 20 sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Face-to-face interview (Control)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery Program
Number of subjects: 50
Study: 33161105

Group type: EXPERIMENTAL
Intervention: Probucol combined with mecobalamin tablets
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (mecobalamin tablets only)
Number of subjects: 104
Study: 35468729

Group type: EXPERIMENTAL
Intervention: Ubrogepant 50 mg
Number of subjects: 1799

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1799
Study: 32779029

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard of care (videos, television, iPad, child life specialist)
Number of subjects: 66
Study: 33631604

Group type: EXPERIMENTAL
Intervention: PFAS exposure (specifically PFOS and N-ethyl-perfluorooctane sulfonamido acetic acid)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: PFOS (linear isomer)
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: N-ethyl-perfluorooctane sulfonamido acetic acid
Number of subjects: 666

Group type: EXPERIMENTAL
Intervention: PFOS and n-PFOS
Number of subjects: 666
Study: 32432550

Group type: EXPERIMENTAL
Intervention: Smartphone-based music intervention (supervised sessions 3 times during stay)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Smartphone-based music intervention (unsupervised use by participant)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Overall feedback from participants
Number of subjects: 81
Study: 35484429

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 10 IU/h
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 5 IU/h
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 2.5 IU/h
Number of subjects: 105
Study: 34750127

Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with an emphasis on quality
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with an emphasis on communication and information
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with cohesiveness among clinicians
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with values alignment between clinicians and leaders
Number of subjects: 165
Study: 34616527

Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional acute angina pectoris drugs
Number of subjects: 88
Study: 33863746

Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen (n=13)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: CPAP treatment (n=17)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (n=13)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH) (n=8)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normoxia (n=7)
Number of subjects: 23
Study: 32894251

Group type: EXPERIMENTAL
Intervention: Remote video-based visits
Number of subjects: 40
Study: 34588252

Group type: EXPERIMENTAL
Intervention: Mirabegron (50 mg orally once a day)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 35393934

Group type: EXPERIMENTAL
Intervention: Brief behavioral treatment for insomnia (BBTI, 4 sessions)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Progressive muscle relaxation therapy (active control)
Number of subjects: 91
Study: 35360485

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine hot ironing technique intervention
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops
Number of subjects: 92
Study: 37244291

Group type: EXPERIMENTAL
Intervention: Daily multivitamin supplement (Centrum Silver)
Number of subjects: 3562

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3562
Study: 33317349

Group type: EXPERIMENTAL
Intervention: 505 change of direction (CoD) test
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: 10-m sprint test
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: change of direction deficit test (CoDD)
Number of subjects: 39
Study: 32234999

Group type: COMPARATOR
Intervention: Sand surface during Single-Leg Landing (SLL) tasks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Land surface during Single-Leg Landing (SLL) tasks
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sand surface during Drop Jump (DJ) tasks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Land surface during Drop Jump (DJ) tasks
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Comparison of SLL tasks between males and females
Number of subjects: 31
Study: 35787963

Group type: EXPERIMENTAL
Intervention: Machine Learning models (random forest, support vector machine [SVM], logistic regression)
Number of subjects: 423

Group type: COMPARATOR
Intervention: Corticosteroid Randomization after Significant Head Injury (CRASH) model
Number of subjects: 423
Study: 34797353

Group type: EXPERIMENTAL
Intervention: CD3+ tumor-infiltrating lymphocytes (TIL)
Number of subjects: 83
Study: 33992767

Group type: EXPERIMENTAL
Intervention: Peer Navigation Social Support for smoking cessation (PNSS-S)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard cessation counseling
Number of subjects: 72
Study: 35654566

Group type: EXPERIMENTAL
Intervention: Brush/Floss/Rinse (BFR)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Brush/Floss (BF)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Brush only (BO)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Brush/Rinse (BR)
Number of subjects: 213
Study: 33114131

Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care control group
Number of subjects: 60
Study: 35894991

Group type: EXPERIMENTAL
Intervention: Functional Motor Control (FMC) exercises
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Therapeutic Exercises (TE)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 33851953

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study: 32912978

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 35797703

Group type: EXPERIMENTAL
Intervention: ToM training
Number of subjects: 90

Group type: COMPARATOR
Intervention: Physical-conversation training
Number of subjects: 90
Study: 34556107

Group type: EXPERIMENTAL
Intervention: Chitosan-based varnish (UNO Gel Bioschell, Germiphene corp.) applied weekly for 6 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-fluoride varnish (Cervitec F, Ivoclar Vivadent) applied weekly for 6 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Both varnishes
Number of subjects: 20
Study: 32215834

Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg daily for 1 week
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 35247108

Group type: EXPERIMENTAL
Intervention: Self-referential stimuli in SART for ADHD group
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Methylphenidate for ADHD group
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Methylphenidate in classroom study
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Free play mind-wandering condition
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control condition (newscast)
Number of subjects: 114
Study: 36089229

Group type: EXPERIMENTAL
Intervention: GLAD programme (8-week exercise and education programme)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Open-label placebo (OLP, 4 intra-articular saline injections over 8 weeks)
Number of subjects: 206
Study: 34532299

Group type: EXPERIMENTAL
Intervention: Rifaximin, 550 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: C. jejuni infection
Number of subjects: 0
Study: 32989073

Group type: EXPERIMENTAL
Intervention: Engaging underserved populations in preventive care through online, personalized, educational material
Number of subjects: 2417

Group type: EXPERIMENTAL
Intervention: Length of the patient‐clinician relationship
Number of subjects: 2417

Group type: EXPERIMENTAL
Intervention: Sharing the decision about screening options with the clinician
Number of subjects: 2417

Group type: EXPERIMENTAL
Intervention: Being given a choice about screening options
Number of subjects: 2417

Group type: EXPERIMENTAL
Intervention: Traditional factors (race, employment, insurance, education)
Number of subjects: 2417
Study: 33926838

Group type: EXPERIMENTAL
Intervention: Focal Cryotherapy (FC)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Active Surveillance (AS)
Number of subjects: 121
Study: 34790373

Group type: EXPERIMENTAL
Intervention: Carbon nanoparticles suspension injections (CNS) administered endoscopically within 24 hours prior to neoadjuvant chemotherapy (NCT).
Number of subjects: 160
Study: 32678789

Group type: EXPERIMENTAL
Intervention: Single-axis force gauge
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single-axis force gauge at fast pace
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current standard measurement methods
Number of subjects: 0
Study: 33523572

Group type: EXPERIMENTAL
Intervention: Infant-directed singing
Number of subjects: 2

Group type: COMPARATOR
Intervention: Infant-directed speech
Number of subjects: 2
Study: 36161778

Group type: EXPERIMENTAL
Intervention: Combined intervention of 25° upper body elevation and hand massage
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study: 32469621

Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 443

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443
Study: 32422373

Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 337

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study: 34533847

Group type: EXPERIMENTAL
Intervention: Cross-sectorial lung team
Number of subjects: 109

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 109
Study: 33591821

Group type: EXPERIMENTAL
Intervention: IMR ≤32 and LVEDP ≤18
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: IMR >32 and LVEDP >18
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: LVEDP >18
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Hospitalization for heart failure
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Major adverse cardiac events
Number of subjects: 131
Study: 35732064

Group type: EXPERIMENTAL
Intervention: Higher Brain Living (HBL) therapy
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (no HBL sessions)
Number of subjects: 77
Study: 33407784

Group type: EXPERIMENTAL
Intervention: Home-based couple visits
Number of subjects: 1080

Group type: COMPARATOR
Intervention: HIV self-testing kits for couple use
Number of subjects: 1080

Group type: COMPARATOR
Intervention: Standard care (male partner clinic invitation letters)
Number of subjects: 1080
Study: 36066854

Group type: EXPERIMENTAL
Intervention: 200 mg/d of trans-resveratrol (RSV) for 3 months (90 days)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 200 mg/d of trans-resveratrol (RSV)
Number of subjects: 5
Study: 32039938

Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopy (RAL)
Number of subjects: 22

Group type: COMPARATOR
Intervention: 3-dimensional conventional laparoscopy (3D-CL)
Number of subjects: 22
Study: 616631076

Group type: EXPERIMENTAL
Intervention: lienal polypeptide injection combined with chemotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: chemotherapy only
Number of subjects: 60
Study: 35695582

Group type: EXPERIMENTAL
Intervention: Mirtazapine (mean dosage = 39.56 mg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 33601937

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) [Octagam 5%]
Number of subjects: 21
Study: 32398120

Group type: EXPERIMENTAL
Intervention: Individualized treatment algorithm based on ultrasonographic examination
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-operative treatment (Control group A)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Operative treatment (Control group B)
Number of subjects: 300
Study: 33165168

Group type: EXPERIMENTAL
Intervention: PGx‐treatment group (200 mg isoniazid)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Standard‐treatment group (300 mg isoniazid)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Reference group (300 mg isoniazid for NAT2 rapid acetylators)
Number of subjects: 100
Study: 35314092

Group type: EXPERIMENTAL
Intervention: Docetaxel treatment (specific dosage and duration not mentioned)
Number of subjects: 2282

Group type: EXPERIMENTAL
Intervention: PSA kinetic metrics (absolute value, best percentage change, tumour growth rate)
Number of subjects: 2282

Group type: EXPERIMENTAL
Intervention: Best percentage change (BPCH)
Number of subjects: 2282
Study: 32145674

Group type: EXPERIMENTAL
Intervention: Active cranial electrotherapy stimulation (CES) - 500μA-2mA for 30 minutes per day for 4 weeks.
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham cranial electrotherapy stimulation (CES) - lower than 100μA for 30 minutes per day for 4 weeks.
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Active cranial electrotherapy stimulation (CES)
Number of subjects: 62
Study: 35984521

Group type: EXPERIMENTAL
Intervention: Preoperative bowel stimulation (10 outpatient sessions within 3 weeks prior to ileostomy closure)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Preoperative bowel stimulation
Number of subjects: 96

Group type: COMPARATOR
Intervention: No stimulation (control group)
Number of subjects: 96
Study: 33949237

Group type: EXPERIMENTAL
Intervention: Awake prone positioning
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study: 34022524

Group type: EXPERIMENTAL
Intervention: Perampanel
Number of subjects: 1374

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1374
Study: 32871556

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Small-Sided Games (SSGs)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Comparison between HIIT and SSGs
Number of subjects: 32
Study: 36266402

Group type: EXPERIMENTAL
Intervention: 1-week residential group program based on mindfulness training, artistic expression, and EMDR group therapy
Number of subjects: 44
Study: 35861215

Group type: EXPERIMENTAL
Intervention: Restorative yoga
Number of subjects: 35

Group type: COMPARATOR
Intervention: Vigorous yoga
Number of subjects: 35
Study: 33317981

Group type: EXPERIMENTAL
Intervention: 1.4 km time trial (TT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 1.2 km, 1.6 km, and 2.0 km time trials (TT)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: 1.2 km to 2.2 km time trials (TT)
Number of subjects: 33
Study: 35443277

Group type: EXPERIMENTAL
Intervention: Memory perfectionism
Number of subjects: 77
Study: 33548743

Group type: EXPERIMENTAL
Intervention: Phonics-based reading intervention program
Number of subjects: 48
Study: 33099934

Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg/3 weeks
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg/3 weeks with primary surgery
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg/3 weeks with secondary debulking surgery
Number of subjects: 106
Study: 32246238

Group type: EXPERIMENTAL
Intervention: Triangular three-port (TTEP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Midline three-port (MTEP)
Number of subjects: 28
Study: 33008855

Group type: EXPERIMENTAL
Intervention: 2-event regimen (2 pills per day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 3-event regimen (3 pills per day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 4-event regimen (4 pills per day)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chewable calcium supplements
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Home-based strategies and counseling
Number of subjects: 48
Study: 36485007

Group type: EXPERIMENTAL
Intervention: Ripretinib 150 mg once daily
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 33872715

Group type: EXPERIMENTAL
Intervention: Mohs micrographic surgery
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Staged excision
Number of subjects: 48

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 48
Study: 32111803

Group type: EXPERIMENTAL
Intervention: MRI after neoadjuvant chemotherapy
Number of subjects: 55
Study: 34903704

Group type: EXPERIMENTAL
Intervention: 3 × 500 mg metronidazole and 3 × 1.5 g cefuroxime intravenously for 3 days starting on the day before RC
Number of subjects: 30

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 30
Study: 32991471

Group type: EXPERIMENTAL
Intervention: High-intensity running exercise under hypoxia (fraction of inspired oxygen 14.5%)
Number of subjects: 21

Group type: COMPARATOR
Intervention: High-intensity running exercise under normoxia (fraction of inspired oxygen 20.9%)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 12-week hypoxic running exercise training program
Number of subjects: 21
Study: 36273227

Group type: EXPERIMENTAL
Intervention: Midwifery-led antenatal pelvic floor muscle exercises (PFME) intervention
Number of subjects: 1400

Group type: COMPARATOR
Intervention: Standard antenatal care (control)
Number of subjects: 1400
Study: 33752119

Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% plus clonidine (2 mcg/kg, maximum of 100 mcg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Ropivacaine 0.5% plus normal saline
Number of subjects: 50
Study: 32513334

Group type: EXPERIMENTAL
Intervention: High-protein diet (HP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard protein diet (SP)
Number of subjects: 50